02Nov
Deal would add heart pumps, a fast-growing part of the medical-device industry, to J&J’s lineup
Abiomed sells Impella heart pumps for treatment of conditions including a heart attack, heart failure and clogged arteries.
Johnson & Johnson JNJ -0.51%decrease; red down pointing triangle
agreed to buy heart-device maker Abiomed Inc. in a $16.6 billion deal that the health-products giant hopes will accelerate its overhaul into a leaner, faster-growing company.
Under the terms, J&J agreed to pay $380 a share upfront, and would pay an additional $35 a share if certain milestones are met. Abiomed shares, which closed at $252.08 Monday, rose 50% to $378.80 on the deal news Tuesday afternoon.
Kindly,Subscribe with your Valid Email Address and receive Relevant Notifications to your active Device with Professionalism.
IMPORTANT NOTICE:Please be mindful of fake sites run by Fraudulent parties posing as Guaranty Affiliates of "XQUISITETRENDZ.COM" and (SITE123),Do not disclose your personal information and financial details to "Malicious and Suspecious Portal" or "Pop-up Messages",without a scrutinized credibility Within the duration you Surf the internet.
Thankyou for the Scheduled Quality Ample Time.
